About Sol-gel (SLGL)
Sol-Gel Technologies Ltd operates as a clinical stage pharmaceutical company. The Company identifies and develops topical dermatological drug products for the treatment of skin diseases. Sol-Gel Technologies markets its products worldwide.
- USD0.87
- USD0.88
- USD0.86
- USD4.05
- -16.70%
- 2M
- 8.14k
- 29.40k
- 25M
- 0.68
- -76.50%
Stock News
2 hours ago
OneWater Marine Inc. (NASDAQ:ONEW) Q2 2024 Earnings Call Transcript
Yahoo
2 hours ago
FuboTV Gaining Popularity North America, High Growth In Paid Subscribers Show
Yahoo
2 hours ago
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Call Transcript
Yahoo
2 hours ago
The No. 1 skill companies are hiring for is also the hardest to find, according to new research
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
